Steve Cartt

Steve Cartt joined Asterias Biotherapeutics, Inc. in February 2016 as Chief Executive Officer. Mr. Cartt served as Chief Operating Officer of Questcor Pharmaceuticals, Inc., from February 2012 until August 2014, when the company was acquired by Mallinckrodt plc. Mr. Cartt served as Chief Operating Officer of the Autoimmune and Rare Diseases Business Unit of Mallinckrodt plc on an interim basis following the merger with Questcor Pharmaceuticals, Inc. from August 2014 until October 2014. Mr. Cartt joined Questcor Pharmaceuticals, Inc. as Executive Vice President, Corporate Development, during March 2005. He was later appointed Chief Business Officer before being appointed Chief Operating Officer. Mr. Cartt was a private consultant from August 2002 until March 2005. From March 2000 through August 2002, Mr. Cartt was the Senior Director of Strategic Marketing for Elan Pharmaceuticals. Prior to that, Mr. Cartt held a variety of R&D and commercial positions at ALZA Corporation during the period July 1985 to March 2000. Mr. Cartt holds a B.S. from the University of California at Davis in biochemistry and an MBA from Santa Clara University.